Ardelyx (ARDX) EBT (2013 - 2026)
Ardelyx (ARDX) posted EBT of -$37.6 million for Q1 2026, down 9299.25% on a QoQ basis from -$400000.0 in Q4 2025, and up 6.67% year-over-year from -$35.2 million in Q1 2025.
Ardelyx (ARDX) EBT (2013 - 2026) Analysis & Trends
Ardelyx's EBT history runs 14 years deep, the most recent figure standing at -$37.6 million for Q1 2026.
- Quarterly EBT rose 6.67% year-over-year to -$37.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$57.9 million (down 9.83% YoY) and the FY2025 annual result came in at -$60.6 million, down 55.98% from the prior year.
- EBT was -$37.6 million for Q1 2026 at Ardelyx, down from -$400000.0 in the prior quarter.
- Across five years, EBT topped out at $10.7 million in Q4 2022 and bottomed at -$40.3 million in Q1 2025.
- A 5-year average of -$15.9 million and a median of -$19.1 million in 2025 frame the typical range for EBT.
- Peak annual rise in EBT reached 129.83% in 2023, while the deepest fall reached 366.19% in 2023.
- Ardelyx's EBT stood at $10.7 million in 2022, then sank by 366.19% to -$28.5 million in 2023, then soared by 116.44% to $4.7 million in 2024, then sank by 108.55% to -$400000.0 in 2025, then tumbled by 9299.25% to -$37.6 million in 2026.
- Business Quant data shows ARDX's EBT at -$37.6 million in Q1 2026, -$400000.0 in Q4 2025, and -$867000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Ardelyx | 1.24 Bn | 999.81 Mn | 89.66 Mn | -37.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.60 Mn |
| Dec 31, 2025 | -400,000.00 |
| Sep 30, 2025 | -867,000.00 |
| Jun 30, 2025 | -19.08 Mn |
| Mar 31, 2025 | -40.29 Mn |
| Dec 31, 2024 | 4.68 Mn |
| Sep 30, 2024 | -766,000.00 |
| Jun 30, 2024 | -16.39 Mn |
| Mar 31, 2024 | -26.40 Mn |
| Dec 31, 2023 | -28.47 Mn |
| Sep 30, 2023 | 6.83 Mn |
| Jun 30, 2023 | -17.12 Mn |
| Mar 31, 2023 | -26.76 Mn |
| Dec 31, 2022 | 10.70 Mn |
| Sep 30, 2022 | -22.89 Mn |
| Jun 30, 2022 | -26.93 Mn |
| Mar 31, 2022 | -28.07 Mn |
| Dec 31, 2021 | -36.23 Mn |
| Sep 30, 2021 | -43.59 Mn |
| Jun 30, 2021 | -45.19 Mn |